The novel hydrogen-PT2385-silncARSR nanocomplex impairs tumor angiogenesis and mitochondrial activity in sunitinib-resistant renal cancer.
Suxian Hu, Yan Zhu, Yi Duan, Liting Wang, Jian Yu, Zhihua Wu, Yourong Duan, Ying Sun · Materials today. Bio · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In a laboratory model, thus, the anti-angiogenic activity of PT2385 (HIF-2α inhibitor) was potentiated by H₂ and silncARSR significantly. The authors concluded that looking forward to future clinical translation, the therapeutic efficacy of this approach could be further enhanced through integration with various innovative strategies, including implantable wireless systems enabling localized irradiation or self-luminescent nanomaterials that eliminate external light dependence [ 67 ], which would allow more precise and controllable light-mediated therapeutic responses in clinical tumors. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. Thus, the anti-angiogenic activity of PT2385 (HIF-2α inhibitor) was potentiated by H₂ and silncARSR significantly.
What the Researchers Studied
The study used a in vitro cell-culture laboratory experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Briefly, PEAL (12.5 mg), Chlα (45 μM) and PT2385 (0.06 mg) were dissolved in 500 μL trichloromethane (organic phase). After that, the rotary evaporator was employed to remove the trichloromethane. 3.5 To decide the optimal irradiation time (660 nm NIR) of generating hydrogen gas, the absorption band of chlorophyll α were measured after 0, 1, 3, 5, 7, 9, 11, 13 min exposure, respectively. Thus, the anti-angiogenic activity of PT2385 (HIF-2α inhibitor) was potentiated by H₂ and silncARSR significantly. The authors concluded that looking forward to future clinical translation, the therapeutic efficacy of this approach could be further enhanced through integration with various innovative strategies, including implantable wireless systems enabling localized irradiation or self-luminescent nanomaterials that eliminate external light dependence [ 67 ], which would allow more precise and controllable light-mediated therapeutic responses in clinical tumors.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The study used a in vitro cell-culture laboratory experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.